Gene · 3113
NIH grants1,839
NIH grants whose papers are about the gene, through NIH's grant-paper links.
601 to 620 of 1,839
Download this page as JSON| Grant | Title | HLA-DPA1 papers | Newest fiscal year |
|---|---|---|---|
| R01AI050529 | Exploiting the antigenic conservation of the Env trimer apex across primate lentiviral lineages for AIDS vaccine design | 1 | 2022 |
| R01AI104739 | COMPUTATIONAL TOOLS FOR THE ANALYSIS OF HIGH-THROUGHPUT IMMUNOGLOBULIN SEQUENCING EXPERIMENTS | 1 | 2022 |
| R01AI127869 | HLA-DO / H2-O: modulation of MHC-II peptide diversity and Treg population control | 1 | 2022 |
| R01AI130945 | Interactions between helminth colonization and the gut microbiota | 1 | 2022 |
| R01AI137174 | Initiators, biomarkers and mechanisms of epithelial dysfunction and immune pathogenesis in chronic rhinosinusitis and aspirin exacerbated respiratory disease (AERD) | 1 | 2022 |
| R01AI140326 | Evolution of Adaptive Immunity | 1 | 2022 |
| R01AR042527 | Oligoclonal T Cell Expansion and Rheumatoid Arthritis | 1 | 2022 |
| R01AR070873 | Atopic Dermatitis and High Resolution HLA | 1 | 2022 |
| R01AR073248 | Molecular Regulation of Stem Cell Quiescence | 1 | 2022 |
| R01AR073311 | Complement in Human Lupus: Deficiencies, Profiles and Complications | 1 | 2022 |
| R01CA173636 | Role of TET2 mutations in malignant transformation and acute myeloid leukemia | 1 | 2022 |
| R01DE027750 | Characterizing head and neck tumor neoantigensand T cells: looking beyond the usual suspects | 1 | 2022 |
| R01DK114345 | Protein Markers to Islet Autoimmunity and T1D Progression | 1 | 2022 |
| R01DK115477 | Notch-mediated 5ARI resistance in human BPH | 1 | 2022 |
| R01DK118946 | Underlying chromatin architecture defines functionality for CFTR expression | 1 | 2022 |
| R01DK122160 | Pathways and critical regulators of early beta-cell dysfunction in type 1 diabetes | 1 | 2022 |
| R01GM126535 | A Personalized Medicine Approach to Improve the Prediction of Azathioprine Toxicity | 1 | 2022 |
| R01GM132713 | Detection and annotation of structural variants from long-read sequencing | 1 | 2022 |
| R01HL106579 | Nucleolin Regulation of miRome by Shear Stress | 1 | 2022 |
| R01HL142049 | Novel integrative approaches for disease phenotyping, utilizing radiomics in Sarcoidosis | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/grants?page=31